Contribution of Antiangiogenic Agents to the Risk of Medication-related Osteonecrosis of the Jaw in Combination with Antiresorptive Agents: Preliminary Results in a Comparative Prospective Report of 59 Oncologic Cases

AIM: The aim of this preliminary study was to evaluate in an oncological population the association risk of antiangiogenic (AA) agents to antiresorptive (AR) agents on the incidence and the severity of medication-related osteonecrosis of the jaw (MRONJ). MATERIALS AND METHODS: In this prospective st...

Descripción completa

Detalles Bibliográficos
Autores principales: Yanni, Antoine, Bouland, Cyril, Monteiro, Raquel, Rodriguez, Alexandra, Loeb, Isabelle, Javadian, Rokneddine, Dequanter, Didier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753918/
https://www.ncbi.nlm.nih.gov/pubmed/36532328
http://dx.doi.org/10.4103/jispcd.JISPCD_110_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753918/
https://www.ncbi.nlm.nih.gov/pubmed/36532328
http://dx.doi.org/10.4103/jispcd.JISPCD_110_22

Ejemplares similares